Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00771134 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of Lu AA39959 in Patients With Bipolar Depression
A Phase 2 study, sponsored by H. Lundbeck A/S.
- Terminated
- Registry status
- Phase 2
- Development phase
- 105
- Enrollment target
NCT00771134: Clinical Trial Phase 2 study, sponsored by H. Lundbeck A/S.
NCT00771134 is a Phase 2 study that was terminated before completion, run by H. Lundbeck A/S. The registered enrollment target is 105 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (21% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00771134, a Phase 2 study, was terminated before completion, sponsored by H. Lundbeck A/S.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 105 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy and safety of Lu AA39959 in the treatment of depression in patients with bipolar disorder.
Interventions
- DRUG Placebo
- DRUG Quetiapine
- DRUG Lu AA39959
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-08 |
| Phase | Phase 2 |
Why NCT00771134 stopped before completion
NCT00771134 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (21% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00771134 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00771134 about?
NCT00771134 is a clinical study titled "Efficacy and Safety of Lu AA39959 in Patients With Bipolar Depression". This study will evaluate the efficacy and safety of Lu AA39959 in the treatment of depression in patients with bipolar disorder.
What is the current status of trial NCT00771134?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 105 participants. The study started on 2008-12. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00771134?
The interventions under investigation include: Placebo (DRUG), Quetiapine (DRUG), Lu AA39959 (DRUG).
Who is sponsoring clinical trial NCT00771134?
This trial is sponsored by H. Lundbeck A/S, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00771134's enrollment target sits among peer trials
105 650th of 2000 higher than 1,341 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia